CA19-9-Low&Lewis (+) pancreatic cancer: A unique subtype.

doi:10.1016/j.canlet.2016.10.046

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

CA19-9-Low&Lewis (+) pancreatic cancer: A unique subtype.

Cancer letters - 28 Jan 2017

Luo Guopei, Liu Chen, Guo Meng, Long Jiang, Liu Zuqiang, Xiao Zhiwen, Jin Kaizhou, Cheng He, Lu Yu, Ni Quanxing, Yu Xianjun

Abstract excerpt

The study was performed to identify unique subtype from the long-term survival (>24 months) patients with advanced pancreatic cancer (1039 cases). Long-term survival patients had higher proportion of low secretion of carbohydrate antigen 19-9 (CA19-9) than that of patients with non long-term survival (P < 0.001). Considering the impact of Lewis status on CA19-9 secretion, Lewis genotypes were further determined...

Topics

Adenocarcinoma
Antineoplastic Agents
CA-19-9 Antigen
Chemoradiotherapy
Chi-Square Distribution
Databases, Factual
Female
Fucosyltransferases
Genetic Predisposition to Disease
Humans
Kaplan-Meier Estimate

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Lewis X Antigen

Male

Middle Aged

Neoplasm Staging

Pancreatic Neoplasms

Phenotype

Proportional Hazards Models

Source

Open in PubMed

Identifiers

PMID: 27840089
DOI: 10.1016/j.canlet.2016.10.046

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CA19-9-Low&Lewis (+) pancreatic cancer: A unique subtype.PMID 27840089Read ↗

New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancer.Semantic proximity Read ↗

Optimize CA19-9 in detecting pancreatic cancer by Lewis and Secretor genotyping.Semantic proximity Read ↗

Lewis Antigen Phenotype and Survival of Patients With Pancreatic Cancer.Semantic proximity Read ↗

A New CA19-9 Cutoff Value Identifies Lewis Antigen Status and Refines Prognostic Stratification in PDAC.Semantic proximity Read ↗

Potential Biomarkers in Lewis Negative Patients With Pancreatic Cancer.Semantic proximity Read ↗

Optimal value of CA19-9 determined by KRAS-mutated circulating tumor DNA contributes to the prediction of prognosis in pancreatic cancer patients.Semantic proximity Read ↗

The relationship between Lewis/Secretor genotypes and serum carbohydrate antigen 19-9 levels in a Korean population.Semantic proximity Read ↗

Identification of KRAS G12V associated clonal neoantigens and immune microenvironment in long-term survival of pancreatic adenocarcinoma.Semantic proximity Read ↗

Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma after Pancreatectomy: TP53 and SMAD4 Mutation Scoring in Combination with CA19-9.Semantic proximity Read ↗

The utility of a novel blood based biomarker in the diagnosis of pancreatic cancerSemantic proximity Read ↗

Investigation of unexpected serum CA19-9 elevation in Lewis-negative cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.